[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343863-105":59,"doc-detail-343863-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","targeting-cd206-macrophages-disrupts-the-establishment-of-a-key-antitumor-immune-axis","Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis","","Targeting CD206+ tumor-associated macrophages with a novel conditional CD206 (Mrc1) knock-in mouse enables visualization and depletion of CD206+ TAMs. Early loss of CD206+ macrophages/monocytes indirectly reduces conventional type I dendritic cells, CD8 T cells, and NK cells in tumors. CD206+ TAMs promote a CXCL9-driven antitumor axis by attracting activated CD8 T cells and sustaining cDC1-supportive Xcl1 and Flt3l programs. Disruption weakens antigen-specific tumor control and impairs Cxcr3-related signatures. In human cancers, a CD206Replete mono/mac signature correlates with CD8 T cell, cDC1, and NK signatures and better survival, challenging the immunosuppressive-only view of CD206+ “M2-like” macrophages.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-cd206-macrophages-disrupts-the-establishment-of-a-key-antitumor-immune-axis/343863/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-cd206-macrophages-disrupts-the-establishment-of-a-key-antitumor-immune-axis/343863.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What strategy was used to target CD206+ macrophages?","Question",{"text":112,"@type":113},"The study generated a novel conditional CD206 (Mrc1) knock-in mouse to specifically visualize and/or deplete CD206+ tumor-associated macrophages.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does early CD206+ macrophage depletion affect tumor immunity?",{"text":117,"@type":113},"Early depletion indirectly leads to loss of conventional type I dendritic cells, CD8 T cells, and NK cells within tumors.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune axis do CD206+ TAMs support?",{"text":121,"@type":113},"CD206+ TAMs robustly express CXCL9, attracting activated CD8 T cells and supporting an NK/CD8 T cell program linked to cDC1-supportive Xcl1 and Flt3l expression.",{"name":123,"@type":110,"acceptedAnswer":124},"How do the findings relate to human cancer outcomes?",{"text":125,"@type":113},"In human cancers, a CD206Replete mono/mac gene signature correlates with CD8 T cell, cDC1, and NK signatures and is associated with better survival, unlike a CD206Depleted signature.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},343863,1790144867,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":26,"preview_page_count":19,"preview_urls":149},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","BRIEF DEFINITIVE REPORT  \nTargeting CD206 + macrophages disrupts the establishment of a key antitumor immune axis  \nArja Ray1,2􀀁, Kenneth H. Hu1,2􀀁, Kelly Kersten1,2􀀁, Tristan Courau1,2􀀁, Nicholas F. Kuhn1,2􀀁, Itzia Zaleta-Linares1,2􀀁, Bushra Samad2,3􀀁 , Alexis J. Combes1,2,3,4􀀁, and Matthew F. Krummel1,2,3􀀁  \nCD206 is a common marker of a putative immunosuppressive “M2” state in tumor-associated macrophages (TAMs). We madea novel conditional CD206 (Mrc1) knock-in mouse to specifically visualize and/or deplete CD206+ TAMs. Early depletion of CD206+ macrophages and monocytes (Mono/Macs) led to the indirect loss of conventional type I dendritic cells (cDC1), CD8 T cells, and NK cells in tumors. CD206+ TAMs robustly expressed CXCL9, contrasting with stress-responsive Spp1-expressing TAMs and immature monocytes, which became prominent with early depletion. CD206+ TAMs differentially attracted activated CD8 T cells, and the NK and CD8 T cells in CD206-depleted tumors were deficient in Cxcr3 and cDC1-supportive Xcl1 and Flt3l expressions. Disrupting this key antitumor axis decreased tumor control by antigen-specific T cells in mice. In human cancers, a CD206Replete, but not a CD206Depleted Mono/Mac gene signature correlated robustly with CD8 T cell, cDC1, and NK signaturesand was associated with better survival. These findings negate the unqualified classification of CD206+ “M2-like”  \nmacrophages as immunosuppressive.  \nIntroduction  \nMacrophages have diverse roles in homeostasis and disease, anda refined understanding of the direct and indirect effects of targeting these cells in tumors is imperative, given the current impetus in developing myeloid targeting therapies for cancer (Binnewies et al., 2018; Goswami et al., 2023; Kowal et al., 2019; Pittet et al., 2022) . While the pro-tumor effects of tumorassociated macrophages (TAMs) have been a dominant focus in the field, strategies for broad targeting of these cells and their monocyte precursors (Mono/Macs) and indeed those that are collectively known as myeloid-derived suppressor cells have met with limited success (Barry et al., 2023; Gomez-Roca et al., 2019). The detrimental effects ofTAMs on antitumor immunity have indeed been highlighted by several critical studies (Broz et al., 2014; Doedens et al., 2010; Kersten et al., 2022; Mitchemet al., 2013; Nixon et al., 2022; Park et al., 2023; Peranzoni et al., 2018; Ruffell et al., 2014) . However, TAMs can also act as organizing factors in antitumor immunity. One of the wellestablished ways macrophages aid antitumor immunity is by CXCL9/10/11 expression (House et al., 2020; Qu et al., 2020), which are ligands for CXCR3-expressing lymphocytes including CD8 T cells and natural killer (NK) cells. The importance of  \nCXCL9 expressing TAMs in organizing immune cells in response to checkpoint blockade has been established in both mouse and human tumors (Bill et al., 2023; House et al., 2020; Qu et al., 2020) . NK cells and activated CD8 T cells, on the other hand, are known to produce chemokines FLT3L and XCL1, supportive of conventional type 1 dendritic cells (cDC1s [Barry et al., 2018; Bttcher et al., 2018]). These cDC1s are well-characterized as antigen-presenting cells that potently stimulate CD8 T cells (Broz et al., 2014; Pittet et al., 2023; Salmon et al., 2016; Schenkelet al., 2021) . Therefore, a cDC1:NK:CD8 T cell module is also associated with antitumor immunity and immune checkpoint blockade (ICB) (Barry et al., 2018; Bttcher et al., 2018) . The context-dependent role ofTAMs related to such modules of reactive immunity in the tumor microenvironment (TME) is not fully elucidated.  \nTo design rational myeloid targeting strategies, there is a need to better understand the diversity and contextual function of macrophages. A widely used strategy for describing macrophage function in tumors has involved an “M1” versus “M2”nomenclature, derived from in vitro skewing with Th1 versus Th2 cytokines, and often equated with pro- and an","cbCaivwpRIRgELBW","https://ap.wps.com/l/cbCaivwpRIRgELBW","pdf",7222932,24,"English","# Introduction\n## Targeting macrophage subsets in tumors\n## The CXCL9/10/11-driven antitumor immune axis\n## Questioning the classic M1/M2 classification","[{\"question\":\"What strategy was used to target CD206+ macrophages?\",\"answer\":\"The study generated a novel conditional CD206 (Mrc1) knock-in mouse to specifically visualize and/or deplete CD206+ tumor-associated macrophages.\"},{\"question\":\"How does early CD206+ macrophage depletion affect tumor immunity?\",\"answer\":\"Early depletion indirectly leads to loss of conventional type I dendritic cells, CD8 T cells, and NK cells within tumors.\"},{\"question\":\"What immune axis do CD206+ TAMs support?\",\"answer\":\"CD206+ TAMs robustly express CXCL9, attracting activated CD8 T cells and supporting an NK/CD8 T cell program linked to cDC1-supportive Xcl1 and Flt3l expression.\"},{\"question\":\"How do the findings relate to human cancer outcomes?\",\"answer\":\"In human cancers, a CD206Replete mono/mac gene signature correlates with CD8 T cell, cDC1, and NK signatures and is associated with better survival, unlike a CD206Depleted signature.\"}]","Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis | PDF",1790052333,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff81cba57df125c289ef4d2529ecdca4.webp",983,1272,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cefaf1fa4b80b11e632fb5a6f6590ce2.webp",982,1270,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0de6f848f3c4a7d2fa897e4b682e2bb.webp",981,1269,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c92c945b565c63fcf66b64f68525e5d3.webp",980,1268]